×
Jupiter Neurosciences Price to Free Cash Flow Ratio 1971-1970 | JUNS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Jupiter Neurosciences price to free cash flow ratio from 1971 to 1970. Price to free cash flow ratio can be defined as
View More
Jupiter Neurosciences Price to Free Cash Flow Ratio 1971-1970 | JUNS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Jupiter Neurosciences price to free cash flow ratio from 1971 to 1970. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Zoetis (ZTS)
$73.8B
Chugai Pharmaceutical (CHGCY)
$70.2B
Takeda Pharmaceutical (TAK)
$41.4B
Merck (MKKGY)
$18.5B
Sandoz Group AG (SDZNY)
$18.2B
Astellas Pharma (ALPMY)
$17.5B
United Therapeutics (UTHR)
$16.1B
Neurocrine Biosciences (NBIX)
$13.7B
Summit Therapeutics (SMMT)
$13.6B
Shionogi (SGIOY)
$11.7B
Madrigal Pharmaceuticals (MDGL)
$6.4B
Orion OYJ (ORINY)
$6.2B
Ionis Pharmaceuticals (IONS)
$5.6B
Corcept Therapeutics (CORT)
$5.4B
Crinetics Pharmaceuticals (CRNX)
$4.9B
PTC Therapeutics (PTCT)
$3.5B
Catalyst Pharmaceuticals (CPRX)
$2.6B
Dyne Therapeutics (DYN)
$2.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.4B
NewAmsterdam Pharma (NAMS)
$2.4B
Centessa Pharmaceuticals (CNTA)
$2.3B
Soleno Therapeutics (SLNO)
$1.9B
Recursion Pharmaceuticals (RXRX)
$1.7B
Xencor (XNCR)
$1.7B
Indivior (INDV)
$1.6B
Evotec AG (EVO)
$1.6B
BioCryst Pharmaceuticals (BCRX)
$1.5B
Guardian Pharmacy Services (GRDN)
$1.4B
Ocular Therapeutix (OCUL)
$1.3B
Aurinia Pharmaceuticals Inc (AUPH)
$1.3B